Apitolisib

(2S)-1-(4-{[2-(2-Amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl}-1-piperazinyl)-2-hydroxy-1-propanon

(2S)-1-(4-{[2-(2-Amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl}-1-piperazinyl)-2-hydroxy-1-propanone

(2S)-1-(4-{[2-(2-Amino-5-pyrimidinyl)-7-méthyl-4-(4-morpholinyl)thiéno[3,2-d]pyrimidin-6-yl]méthyl}-1-pipérazinyl)-2-hydroxy-1-propanone

(2S)-1-(4-{[2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}piperazin-1-yl)-2-hydroxypropan-1-one

1-Propanone, 1-[4-[[2-(2-amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]-1-piperazinyl]-2-hydroxy-, (2S)-

1032754-93-0

1C854K1MIJ

Apitolisib

apitolisib

apitolisib

apitolisibum

(2S)-1-4-2-(2-amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)thieno3,2-dpyrimidin-6-ylmethyl-1-piperazinyl-2-hydr oxy-1-propanone

(2S)-1-[4-[[2-(2-amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]-1-piperazinyl]-2-hydroxy-1-propanone

(2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one

(S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one

(S)-1-4-2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno3,2-dpyrimidin-6-ylmethylpiperazin-1-y

(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1 -one

(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-on

95%

Apitolisib (GDC-0980, RG7422)

apitolisib(gdc-0980)

apitolisibum

C[C@H](O)C(=O)N1CCN(CC2=C(C)C3=NC(=NC(N4CCOCC4)=C3S2)C2=CN=C(N)N=C2)CC1

GDC-0980 (Apitolisib)

gdc0980(rg7422)

GNE 390; GDC 0980; RG 7422

MFCD20274520

PK3CA_HUMAN

RG 7422; GNE 390; Apitolisib

апитолисиб

أبيتوليسيب

阿哌利塞